Evidence-based recommendations on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. This involves placing a device under the skin of the chest, which ...

In a prospective global study, extravascular implantable cardioverter–defibrillators with a substernal lead were implanted safely and were able to detect and terminate induced ventricular arrhythmias ...

New System Builds On Sprint Quattro® Lead, Adding to the Company’s Portfolio of Innovative Technologies Proven to Treat Heart Rhythm Disorders MINNEAPOLIS – Medtronic, Inc. today announced the U.S.

Joseph Souza, MD, a cardiac electrophysiologist at Pikeville Medical Center, successfully performed Eastern Kentucky’s first ...

Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest DUBLIN - Sept. 14, 2015 - Medtronic plc today announced that it has received the first ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...

SIMS Hospital saved the life of a 65-year-old religious scholar who developed a life-threatening ventricular tachycardia (VT) storm following a complex redo coronary artery bypass grafting. The ...

Current evidence on the safety and efficacy of subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death is adequate to support the use of this procedure ...

An extravascular ICD with a substernal lead might retain the benefits, and avoid the risks, of transvenous and subcutaneous ICDs, but data on safety and efficacy are needed. New research findings are ...